Systemic administration of lipopolysaccharide impairs glutathione redox state and object recognition in male mice. The effect of PARP-1 inhibitor

Folia Neuropathologica

Volumn 47, Issue 4, 2009, Pages 321-328

  Jacewicz, Maria ^a   Czapski, Grzegorz A ^a   Katkowska, Inna ^b   Strosznajder, Robert P ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b INSTITUTE OF BIOCHEMISTRY   (Belarus)

Author keywords

3 Aminobenzamide; Brain; Lipopolysaccharide; Memory

Indexed keywords

3 AMINOBENZAMIDE; DISULFIDE; GLUTATHIONE; GLUTATHIONE REDUCTASE; LIPOPOLYSACCHARIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1 INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EVALUATION; GENE CONTROL; INFLAMMATION; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; OXIDATION REDUCTION STATE; RECOGNITION; SIGNAL TRANSDUCTION; SPATIAL MEMORY; SPECTROPHOTOMETRY;

EID: 75149179525     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Akerboom TPM, Sies H. Assay for glutathione and glutathione mixed disulfides in biological samples. Methods Enzymol 1981; 77: 373-382.
2. Asakawa T, Matsushita S. Coloring conditions of thiobarbituric acid test for detecting lipid hydriperoxides. Lipids 1980; 15: 137-140.
3. Babcock AA, Wirenfeldt M, Holm T, Nielsen HH, Dissing-Olesen L, Toft-Hansen H, Millward JM, Landmann R, Rivest S, Finsen B, Owens T. Toll-Like Receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J Neurosci 2006; 26: 12826-12837.
4. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985; 13: 484-490.
5. Chiarugi A. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. Br J Pharmacol 2002; 137: 761-770.
6. Chiarugi A. Poly(ADP-ribosyl)ation and stroke. Pharmacol Res 2005; 52: 15-24.
7. Cuzzocrea S. Shock, inflammation and PARP. Pharmacol Res 2005; 52: 72-82.
8. Czapski GA, Cakala M, Chalimoniuk M, Gajkowska B, Strosznajder JB. Role of nitric oxide in the brain during lipopolysaccharide-evoked systemic inflammation. J Neurosci Res 2007; 85: 1694-1703.
9. Czapski GA, Cakala M, Gajkowska B, Strosznajder JB. Poly(ADP-ribose) polymerase-1 inhibition protects the brain against systemic inflammation. Neurochem Int 2006; 49: 751-755.
10. Czapski GA, Chalimoniuk M, Jacewicz M, Gajkowska B, Smialowska M, Strosznajder JB. Systemic inflammation leads to up-regulation of prooxidative genes and to activation of death signaling in hippocampus. Acta Neurobiol Exp 2009; 318.
11. Dringen R, Gutterer JM, Hirrlinger J. Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 2000; 267: 4912-4916.
12. Ennaceur A, Delacour J. A new one-trial test for neurobiological studies of memory in rats 1: behavioral data. Behav Brain Res 1988; 31: 47-59.
13. Haddad M, Rhinn H, Bloquel C, Coqueran B, Szabo C, Plotkine M, Scherman D, Margail I. Anti-inflammatory effects of PJ34, a poly(ADPribose)polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol 2006; 149: 23-30.
14. Johnson AB, Bake S, Lewis DK, Sohrabji F. Temporal expression of IL-1beta protein and mRNA in the brain after systemic LPS injection is affected by age and estrogen. J Neuroimmunol 2006; 174: 82-91.
15. Kelly A, Vereker E, Nolan Y, Brady M, Barry C, Loscher CE, Mills KH, Lynch MA. Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1β on long term potentiation in rat dentate Gyrus. J Biol Chem 2003; 278: 19453-19462.
16. Kielian T. Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 2006; 83: 711-730.
17. Kosiorek P, Hryniewicz A, Bialuk I, Zawadzka A, Winnicka MM, Cannabinoids alter recognition memory in rats. Pol J Pharmacol 2003; 55: 903-910.
18. Liew FY, Xu D, Brint EK, O'Neill LA. Negativeregulation of toll-like receptor-mediated immuneresponses. Nat Rev Immunol 2005; 5: 446-458.
19. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
20. Lucas SM, Rothwell NJ, Gibson RM. The role ofinflammation in CNS injury and disease. Br J Pharmacol 2006; 147: 232-240.
21. Maslinska D, Laure-Kamionowska M, Maslinski S. Toll-like receptors in rat brains injured by hypoxicischaemiaor exposed to staphylococcal alpha-toxin. Folia Neuropathol 2004; 42: 125-132.
22. Matyja E, Taraszewska A, Nagańska E, Grieb P, Rafałowska J. CDP-choline protects motor neurons against apoptotic changes in a model of chronic glutamate excitotoxicity in vitro. Folia Neuropathol 2008; 46: 139-148.
23. Moroni F. Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage. Curr Opin Pharmacol 2008; 8: 96-103.
24. Morris R, Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47-60.
25. Mota RA, Sánchez-Bueno F, Saenz L, Hernández-Espinosa D, Jimeno J, Tornel PL, Martínez-Torrano A, Ramírez P, Parrilla P, Yélamos J. Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury. Lab Investn 2005; 85: 1250-1262.
26. Okouchi M, Okayama N, Aw TY. Preservation of Cellular Glutathione Status and Mitochondrial Membrane Potential by N-Acetylcysteine and Insulin Sensitizers Prevent Carbonyl Stress-Induced Human Brain Endothelial Cell Apoptosis. Curr Neurovasc Res 2009; 6: 267-278.
27. Quan N, Stern EL, Whiteside MB, Herkenham M. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol 1999; 93: 72-80.
28. Scott GS, Kean RB, Mikheeva T, Fabis MJ, Mabley JG, Szabó C, Hooper DC. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2- yl)-N,N-dimethylacetamide. HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. J Pharmacol Exp Ther 2004; 310: 1053-1061.
29. Semmler A, Frisch C, Debeir T, Ramanathan M, Okulla T, Klock-gether T, Heneka MT. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp Neurol 2007; 204: 733-740.
30. Semmler A, Hermann S, Mormann F, Weberpals M, Paxian SA, Okulla T, Schäfers M, Kummer MP, Klockgether T, Heneka MT. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation 2008; 5: 38.
31. Semmler A, Okulla T, Sastre M, Dumitrescu-Ozimek L, Heneka MT. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat 2005; 30: 144-157.
32. Songin M, Jeśko H, Czapski G, Adamczyk A, Strosznajder RP. GSK-3beta and oxidative stress in aged brain. Role of poly(ADP-ribose) polymerase-1. Folia Neuropathol 2007; 45: 220-229.
33. Soriano FG, Liaudet L, Szabó E, Virág L, Mabley JG, Pacher P, Szabó C. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock 2002; 17: 286-292.
34. Sparkman NL, Martin A, Calvert WS, Gary W, Boehm GW. Effects of intraperitoneal lipopolysaccharide on Morris maze performance in year-old and 2-month-old female C57BL/6J mice. Behav Brain Res 2005; 159: 145-151.
35. Strosznajder JB, Jȩśko H, Strosznajder RP. Age-related alteration of poly(ADP-ribose)polymerase activity in different parts of the brain. Acta Biochim Pol 2000; 47: 331-337.
36. Strosznajder R, Gadamski R, Walski M, Inhibition of poly(ADP-ribose) polymerase activity protects hippocampal cells against morphological and ultrastructural alteration evoked by ischemia-reperfusion injury. Folia Neuropathol 2005; 43: 156-165.
37. Strosznajder R, Gajkowska B. Effect of 3-aminobenzamide on Bcl-2, Bax and AIF localization in hippocampal neurons altered by ischemia-reperfusion injury. The immunocytochemical study. Acta Neurobiol Exp 2006; 66: 15-22.
38. Strosznajder RP, Gadamski R, Czapski GA, Jesko H, Strosznajder JB. Poly(ADP-ribose) polymerase during reperfusion after transient forebrain ischemia: its role in brain edema and cell death. J Mol Neurosci 2003; 20: 61-72.
39. Strosznajder RP, Jesko H, Zambrzycka A. Poly(ADP-ribose) polymerase: the nuclear target in signal transduction and its role in brain ischemia-reperfusion injury. Mol Neurobiol 2005; 31: 149-167.
40. Szabo C. Poly(ADP-ribose)polymerase activation by reactive nitrogen species-Relevance for the pathogenesis of inflammation. Nitric Oxide 2006; 14: 169-179.
41. Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, Lathia JD, Siler DA, Chigurupati S, Ouyang X, Magnus T, Camandola S, Mattson MP. Pivotalrole for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci 2007; 104: 13798-13803.
42. Tarozzi A, Morroni F, Merlicco A, Hrelia S, Angeloni C, Cantelli-Forti G, Hrelia P. Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line. J Neurochem 2009; 111: 1161-1171.
43. Trendelenburg G. Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response? J Cereb Blood Flow Metab 2008; 28: 867-881.
44. Winnicka MM. Dopaminergic projection to the nucleus accumbens mediates the memory-enhancing effect of angiotensins in rats. Pharmacol Biochem Behav 1999; 62: 625-630.
45. Ziegler G, Harhausen D, Prinz V, Konig J, Schepers C, Rohr C, Hoffmann O, Lehrach H, Nietfeld W, Trendelenburg G. TLR has a detrimental role in mouse transient focal cerebral ischemia. Biochem Biophys Res Commun 2007; 359: 574-579.